By Abigail Townsend
Date: Wednesday 07 May 2025
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
Prasad, an oncologist who has been vocal in his criticism of the FDA's leadership as well as Covid-19 mandates, was named...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news